Citation Formats
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

O. Saatci Et Al. , "Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer," NATURE COMMUNICATIONS , vol.11, no.1, 2020

Saatci, O. Et Al. 2020. Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer. NATURE COMMUNICATIONS , vol.11, no.1 .

Saatci, O., Kaymak, A., Raza, U., Ersan, P., Akbulut, O., Banister, C., ... Sikirzhytski, V.(2020). Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer. NATURE COMMUNICATIONS , vol.11, no.1.

Saatci, O Et Al. "Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer," NATURE COMMUNICATIONS , vol.11, no.1, 2020

Saatci, O Et Al. "Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer." NATURE COMMUNICATIONS , vol.11, no.1, 2020

Saatci, O. Et Al. (2020) . "Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer." NATURE COMMUNICATIONS , vol.11, no.1.

@article{article, author={O Saatci Et Al. }, title={Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer}, journal={NATURE COMMUNICATIONS}, year=2020}